Abstract
Emerging industries such as biotechnology can be growth engines and promised to transform the troubled healthcare. Even after three decades, vast gap between the promise of biotech and reality, hint at some structural challenges. The industry faces dilemma on organizational, knowledge and strategy fronts as reflected in its financial performance. An attempt is being made in this exploratory paper to evolve the context of cooperative strategies for innovation taking case of biopharmaceutical firms. We explore if the inter-firm cooperative strategies in large capable countries such as India and Japan can be evolved for innovation to address the dilemma. For the purpose, a framework of metanational approach was selected to address issue of domestic or international cooperation.
